Xponance LLC Grows Stock Position in Danaher Corporation $DHR

Xponance LLC lifted its stake in Danaher Corporation (NYSE:DHR) by 4.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,611 shares of the conglomerate’s stock after buying an additional 4,822 shares during the period. Xponance LLC’s holdings in Danaher were worth $23,490,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of DHR. Sivia Capital Partners LLC increased its holdings in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the period. First Trust Advisors LP increased its holdings in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares during the period. Main Street Financial Solutions LLC increased its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC increased its holdings in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC increased its holdings in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.6%

DHR stock opened at $180.65 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business’s 50 day moving average price is $181.15 and its two-hundred day moving average price is $204.96. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market capitalization of $127.86 billion, a price-to-earnings ratio of 34.94, a price-to-earnings-growth ratio of 2.45 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the business earned $1.88 EPS. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. As a group, analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. Barclays cut their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Piper Sandler initiated coverage on Danaher in a research note on Thursday. They issued a “neutral” rating and a $200.00 target price on the stock. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Finally, Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.